Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ari Goldminz, M.D.

Title
Institution
Department
Address

Biography
Brigham & Women's Hospital, Boston, MA06/2018Contact Dermatitis and Occupational Dermatology
Tufts Medical Center, Boston, MA06/2017Dermatology
Tufts U School Med, Boston, MAMD05/2013
Emory University, Atlanta, GABA05/2008

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Goldminz AM, Scheinman PL. Comparison of Nickel Sulfate 2.5% and Nickel Sulfate 5% for Detecting Nickel Contact Allergy. Dermatitis. 2018 Nov/Dec; 29(6):321-323. PMID: 30422885.
    View in: PubMed
  2. Goldminz AM, Scheinman PL. A case series of dupilumab-treated allergic contact dermatitis patients. Dermatol Ther. 2018 Sep 24; e12701. PMID: 30246906.
    View in: PubMed
  3. Goldminz AM, Wald MS, Scheinman PL. Positive Occluded Patch Test in the Face of Negative Repeat Open Application Test. Dermatitis. 2018 May/Jun; 29(3):162-163. PMID: 29762209.
    View in: PubMed
  4. Goldminz AM, Wald MS, Scheinman PL. Negative Repeat Open Application Test With an Extreme Positive Occluded Patch Test for a Fragrant Lotion Preserved With a Formaldehyde Releaser. Dermatitis. 2018 Apr 25. PMID: 29698356.
    View in: PubMed
  5. Joshipura D, Plotnikova N, Goldminz A, Deverapalli S, Turkowski Y, Gottlieb A, Rosmarin D. Importance of light in the treatment of vitiligo with JAK-inhibitors. J Dermatolog Treat. 2018 Feb; 29(1):98-99. PMID: 28581823.
    View in: PubMed
  6. Joshipura D, Goldminz A, Greb J, Gottlieb A. Acitretin for the treatment of recalcitrant plantar warts. Dermatol Online J. 2017 Mar 15; 23(3). PMID: 28329527.
    View in: PubMed
  7. Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Psoriasis. Nat Rev Dis Primers. 2016 11 24; 2:16082. PMID: 27883001.
    View in: PubMed
  8. Greb JE, Goldminz AM, Rosmarin D. Adalimumab for the treatment of actinic granuloma. Dermatol Ther. 2017 May; 30(3). PMID: 27681651.
    View in: PubMed
  9. Greb JE, Gottlieb AB, Goldminz AM. High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum. Dermatol Ther. 2016 Nov; 29(6):482-483. PMID: 27502191.
    View in: PubMed
  10. Greb JE, Goldminz AM, Gottlieb AB. Insights on methotrexate in psoriatic disease. Clin Immunol. 2016 Nov; 172:61-64. PMID: 27455859.
    View in: PubMed
  11. Gottlieb AB, Greb JE, Goldminz AM. Psoriasis Trends and Practice Gaps. Dermatol Clin. 2016 Jul; 34(3):235-42. PMID: 27363878.
    View in: PubMed
  12. Rothstein BE, McQuade B, Greb JE, Goldminz AM, Gottlieb AB. Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis. J Drugs Dermatol. 2016 May 01; 15(5):648-9. PMID: 27168275.
    View in: PubMed
  13. Goldminz AM, Suárez-Fariñas M, Wang AC, Dumont N, Krueger JG, Gottlieb AB. Methotrexate improves pro- and anti-atherogenic genomic expression in psoriatic skin. J Dermatol Sci. 2016 Jun; 82(3):207-9. PMID: 27005302.
    View in: PubMed
  14. Goldminz AM, Suárez-Fariñas M, Wang AC, Dumont N, Krueger JG, Gottlieb AB. CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial. JAMA Dermatol. 2015 Aug; 151(8):837-46. PMID: 25946554.
    View in: PubMed
  15. Goldminz AM, Buzney CD, Kim N, Au SC, Levine DE, Wang AC, Volf EM, Yaniv SS, Kerensky TA, Bhandarkar M, Dumont NM, Lizzul PF, Loo DS, Kulig JW, Brown ME, Lopez-Benitez JM, Miller LC, Gottlieb AB. Prevalence of the metabolic syndrome in children with psoriatic disease. Pediatr Dermatol. 2013 Nov-Dec; 30(6):700-5. PMID: 24016334.
    View in: PubMed
  16. Goldminz AM, Gottlieb AB. Noninfectious granulomatous dermatitides: a review of 8 disorders (Part 1 of 3). Semin Cutan Med Surg. 2013 Sep; 32(3):177-82. PMID: 24175405.
    View in: PubMed
  17. Goldminz AM, Wolpowitz D, Gottlieb AB, Krathen MS. Congenital subungual melanocytic nevus with a pseudo-Hutchinson sign. Dermatol Online J. 2013 Apr 15; 19(4):8. PMID: 24021368.
    View in: PubMed
  18. Kumar N, Goldminz AM, Kim N, Gottlieb AB. Phosphodiesterase 4-targeted treatments for autoimmune diseases. BMC Med. 2013 Apr 04; 11:96. PMID: 23557064; PMCID: PMC3616808.
  19. Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. NF-?B: an essential transcription factor in psoriasis. J Dermatol Sci. 2013 Feb; 69(2):89-94. PMID: 23219896.
    View in: PubMed
  20. Goldminz AM, Botto NC, Gottlieb AB. Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab. J Am Acad Dermatol. 2012 Nov; 67(5):e237-8. PMID: 23062936.
    View in: PubMed
  21. Goldminz AM, Gottlieb AB. Ustekinumab for psoriasis and psoriatic arthritis. J Rheumatol Suppl. 2012 Jul; 89:86-9. PMID: 22751602.
    View in: PubMed
  22. Au SC, Goldminz AM, Loo DS, Dumont N, Levine D, Volf E, Michelon M, Wang A, Kim N, Yaniv S, Lizzul PF, Kerensky T, Lopez-Benitez JM, Natter M, Miller L, Pelajo CF, Davis T, Gottlieb AB. Association between pediatric psoriasis and the metabolic syndrome. J Am Acad Dermatol. 2012 Jun; 66(6):1012-3. PMID: 22583717.
    View in: PubMed
  23. Au SC, Goldminz AM, Kim N, Dumont N, Michelon M, Volf E, Hession M, Lizzul PF, Andrews ID, Kerensky T, Wang A, Yaniv S, Gottlieb AB. Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis. J Dermatolog Treat. 2013 Jun; 24(3):179-87. PMID: 22390688.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Goldminz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (101)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.